Text Size

TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2007 by Shanghai University of Traditional Chinese Medicine.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Shanghai University of Traditional Chinese Medicine
ClinicalTrials.gov Identifier:
NCT00540397
First received: October 5, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted
  Purpose

To Elucidate and Confirm the Theory of XuSunShengJi in the Traditional Chinese Medicine Etiological Pathogenesis of Liver Cirrhosis.


Condition Intervention
Liver Cirrhosis
 Drug: Fuzhenghuayu Tablet, Huangqi Decoction Granule

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Traditional Chinese Medicine Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis

Resource links provided by NLM:

MedlinePlus related topics: Cirrhosis
U.S. FDA Resources

Further study details as provided by Shanghai University of Traditional Chinese Medicine:

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • With 6 month of chronic liver disease history, and positive serum HBsAg

Exclusion Criteria:

  • Other chronic hepatitis and liver cirrhosis of non-hepatitis B
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00540397

Contacts
Contact: Lie-ming Xu, Professor 00-86-21-51328888 ext 8112 xulieming@shutcm.edu.cn

Locations
China, Shanghai
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Recruiting
Shanghai, Shanghai, China, 200021
Contact: Lie-ming Xu, Professor     0086-21-51328888 ext 8112        
Sponsors and Collaborators
Shanghai University of Traditional Chinese Medicine
Investigators
Principal Investigator: Ping Liu, Professor Shanghai University of Traditional Chinese Medicine
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00540397     History of Changes
Other Study ID Numbers: 2006CB504801
Study First Received: October 5, 2007
Last Updated: October 5, 2007
Health Authority: China: Ministry of Health

Additional relevant MeSH terms:
Liver Cirrhosis
Fibrosis
Liver Diseases
Digestive System Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 23, 2013